A phase III study for evaluation of immunogenicity and reactogenicity of Fluarix (Influsplit SSW) 2006/2007 in people aged 18 years or above.
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 02 Dec 2006 New trial record.